Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · NJ, IL, PA · Nov 12, 2019 → Jul 8, 2025
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:40 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Patrick J. Morris is listed as an executive officer and director on 32 SEC Form D filings by 11 issuers between Oct 2016 and Jul 2025. Largest by amount reported sold: Castle Creek Biosciences, Inc. (Exton, PA — biotechnology — 2018–2025; $560.5M reported sold to 54 investors), Paragon Biosciences Emalex Capital, Inc. (Chicaco, IL — pharmaceuticals — 2018–2025; $270M reported sold to 42 investors), Harmony Biosciences II, Inc. (Plymouth Meeting, PA — pharmaceuticals — 2017–2019; $270M reported sold to 30 investors), Evozyne, Inc. (Chicago, IL — biotechnology — 2020–2023; $81M reported sold to 29 investors), Castle Creek Pharmaceuticals, LLC (Bedminster, NJ — pharmaceuticals — 2016; $48M reported sold to 6 investors) and 6 more (all listed below).
What this means That is a lot of deals — 11 separate companies raised money with this person listed as executive officer and director, over about 9 years. Across those companies the filings report $1.3B sold in total.
Listed alongside Jeffrey Aronin (29 shared filings), ANTONIO GRACIAS (26 shared filings), Darien Parhad (23 shared filings), Timothy Cunniff (10 shared filings), Matthew J. Gantz (4 shared filings) and 33 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Patrick. Each name links to their own page.
8 of the issuers belong to the sponsor group Paragon Biosciences (8 issuers, $446.3M reported sold, 2016–2025).
What this means A sponsor group is one team that sets up a new company for each deal. Paragon Biosciences has 8 companies on file and $446.3M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 14 bankruptcy cases matching the name listed in Key records below.
What this means 14 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 32 public filings for Patrick J. Morris and found 21 differences, 1 worth asking the sponsor about: 8 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Patrick J. Morris has not run yet — it is joining a line of 55,336 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.
Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:40 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Patrick J. Morris..
State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).
14 cases: 14 closed (disposition not in docket feed)
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:40 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
21 differences found between the filings for Patrick J. Morris — 1 worth asking about (compared 32 filings on Oct 24, 2026)
United States Bankruptcy Court, D. New Jersey docket "Blue Ridge Foods, LLC v. Aronin" filed Jul 24, 2012, closed Aug 17, 2012. Jeffrey Aronin (listed on the same filings) is listed as Defendant ("Aronin"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
United States Bankruptcy Court, N.D. Illinois docket "Cunniff. LTD v. Anderson" filed Jan 12, 2004, closed Dec 20, 2004. Timothy Cunniff (listed on the same filings) is listed as Plaintiff ("Cunniff. LTD"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
The Oct 6, 2017 Form D lists Octagon Capital Group, LLC as promoter of the issuer and also as a person receiving sales compensation (CRD 173341). Sales commissions reported on this filing: $5,867,000.
What this means The same person is listed as running the company and as being paid to sell its securities. Ask how much and on what terms.
The Oct 14, 2016 Form D lists Octagon Capital Group, LLC as promoter of the issuer and also as a person receiving sales compensation (CRD 173341).
What this means The same person is listed as running the company and as being paid to sell its securities. Ask how much and on what terms.
Form D filed 249 days after the first sale — CIRC Biosciences, Inc. · Form D filed 170 days after the first sale — Paragon Biosciences Emalex Capital, Inc. · Form D filed 16 days after the first sale — CIRC Biosciences, Inc. · Form D filed 16 days after the first sale — Castle Creek Biosciences, Inc. · Form D filed 45 days after the first sale — CIRC Biosciences, Inc. · and 3 more
What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.
The latest filing for this offering is dated Sep 29, 2023 (first sale Sep 14, 2023). It reports $81,000,122 sold of $100,000,001 offered. No later amendment is in our index as of Oct 24, 2026.
What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.
The latest filing for this offering is dated Apr 22, 2021 (first sale Apr 9, 2021). It reports $54,183,709 sold of $59,183,711 offered. No later amendment is in our index as of Oct 24, 2026.
What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.
The Nov 10, 2022 filing lists Patrick J. Morris as executive officer, director; the Mar 25, 2025 Form D/A lists executive officer.
What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.
The Jul 9, 2021 filing lists Patrick J. Morris as executive officer, director; the Feb 3, 2022 Form D lists director.
What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.
The Mar 25, 2025 filing says $242,000,000 offered; the Jul 8, 2025 Form D/A says $270,000,000.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The Nov 10, 2022 filing says $250,000,000 offered; the Mar 25, 2025 Form D/A says $242,000,000.
What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.
The Aug 14, 2018 filing says $6,925,000 offered; the Dec 7, 2018 Form D/A says $9,375,000.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The Nov 10, 2022 filing lists a minimum of $8,372; the Mar 25, 2025 Form D/A lists $1,072.
What this means A different minimum usually means the offering terms changed. Check which terms apply to you.
listed as "Patrick Morris" on 14 filings (from Oct 14, 2016), and "Patrick J. Morris" on 18 filings (from Nov 12, 2019).
What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.
"Pharmaceuticals" (Oct 24, 2018 to Jan 21, 2020); then "Biotechnology" (Jul 9, 2021 to Feb 25, 2025).
What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.
This page covers filings where the address state is NJ or IL or PA. A separate record, "PATRICK MORRIS" with address state A6, is listed on 1 filing — most recently by Binovi Technologies Corp. (Oct 21, 2020). Both records have filings in the same period (Oct 21, 2020).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is NJ or IL or PA. A separate record, "Patrick Morris" with address state AK, is listed on 1 filing — most recently by NordAq Energy Inc. (Jul 19, 2019). The two records do not overlap in time: this page runs Nov 12, 2019 to Jul 8, 2025; the other has one filing dated Jul 19, 2019.
What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.
The people listed on the Jan 21, 2020 filing give Parsippany, NJ; on the Jul 9, 2021 filing they give Exton, PA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
The people listed on the Oct 3, 2019 filing give Northbrook, IL; on the Mar 12, 2021 filing they give Chicago, IL.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
The people listed on the Jan 18, 2018 filing give Northbrook, IL; on the Aug 22, 2019 filing they give Plymouth Meeting, PA. The address now on file (630 W Germantown Pike, Suite 215, Plymouth Meeting, PA) is a registered-agent or shared-office address used by 27 issuers.
What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.
NJ on 4 filings (Oct 14, 2016 to Jan 21, 2020); IL on 27 filings (Oct 6, 2017 to Jul 8, 2025); PA on 1 filing (Aug 22, 2019).
What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
16 of 26 offerings report sales commissions totalling $28,984,019; 0 report finder's fees; 0 report proceeds to related persons.
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Jul 8, 2025 D/A Paragon Biosciences Emalex Capital, Inc. File 021-463914 | $5,669,958 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Feb 25, 2025 D Castle Creek Biosciences, Inc. File 021-539194 | $2,750,000 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Oct 7, 2024 D CIRC Biosciences, Inc. File 021-526087 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 1, 2024 D CIRC Biosciences, Inc. File 021-512128 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Sep 29, 2023 D Evozyne, Inc. File 021-493466 | $2,046,080 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Nov 4, 2022 D Paragon Biosciences Emalex Capital, Inc. File 021-463904 | $171,956 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| May 2, 2022 D Castle Creek Biosciences, Inc. File 021-444058 | $1,694,611 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Feb 3, 2022 D Castle Creek Biosciences, Inc. File 021-432178 | $625,000 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Jul 9, 2021 D Castle Creek Biosciences, Inc. File 021-405683 | $625,000 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Apr 22, 2021 D Evozyne, Inc. File 021-396695 | $1,613,675 | $0 | $0 | Paragon Health Capital BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Mar 12, 2021 D/A Paragon Biosciences Emalex Capital, Inc. File 021-392044 | $1,500,000 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Dec 7, 2020 D CIRC Biosciences, Inc. File 021-382358 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 4, 2020 D Paragon Biosciences CIRC Holdings, LLC File 021-382211 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 7, 2020 D Evozyne, Inc. File 021-366518 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 7, 2020 D Paragon Biosciences Evozyne Holdings, LLC File 021-366524 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 7, 2020 D Paragon Biosciences Evozyne Capital, LLC File 021-366520 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 21, 2020 D Castle Creek Biosciences, Inc. File 021-358609 | $710,045 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Nov 12, 2019 D Paragon Biosciences Qlarity Capital, Inc. File 021-353125 | $450,000 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Oct 3, 2019 D Paragon Biosciences Emalex Capital, Inc. File 021-350344 | $1,122,700 | $0 | $0 | Paragon Health Capital, LLC BrokerCheck CRD 300729 ↗ | EDGAR ↗ |
| Aug 22, 2019 D Harmony Biosciences II, Inc. File 021-347211 | $1,000,000 | $0 | $0 | OCTAGON CAPITAL GROUP, LLC BrokerCheck CRD 173341 ↗ | EDGAR ↗ |
| Dec 7, 2018 D/A Paragon Biosciences Emalex Capital, Inc. File 021-319146 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Oct 24, 2018 D Castle Creek Biosciences, Inc. File 021-324223 | $1,217,994 | $0 | $0 | Octagon Capital Group, LLC BrokerCheck CRD 173341 ↗ | EDGAR ↗ |
| Aug 29, 2018 D Paragon Biosciences Skyline Capital, LLC File 021-320343 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 18, 2018 D Harmony Biosciences II, Inc. File 021-303616 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Oct 6, 2017 D Harmony Biosciences II, Inc. File 021-296157 | $5,867,000 | $0 | $0 | Octagon Capital Group, LLC BrokerCheck CRD 173341 ↗ | EDGAR ↗ |
| Oct 17, 2016 D/A Castle Creek Pharmaceuticals, LLC File 021-272558 | $1,920,000 | $0 | $0 | Octagon Capital Group, LLC BrokerCheck CRD 173341 ↗ | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Patrick J. Morris on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $270M from 42 investors (100% of the $270M target) as of the latest filing. Patrick is listed as executive officer, director on 10 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $560.5M from 54 investors (100% of the $75M target) as of the latest filing. Patrick is listed as director, executive officer on 6 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $16.8M from 19 investors (100% of the $250K target) as of the latest filing. Patrick is listed as executive officer, director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $81M from 29 investors (81% of the $100M target) as of the latest filing. Patrick is listed as executive officer, director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $15.8M from 29 investors (100% of the $15.8M target) as of the latest filing. Patrick is listed as executive officer, director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $9M from 26 investors (100% of the $9M target) as of the latest filing. Patrick is listed as executive officer, director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $9.47M from 2 investors (100% of the $9.47M target) as of the latest filing. Patrick is listed as executive officer, director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $15M from 1 investor (100% of the $15M target) as of the latest filing. Patrick is listed as executive officer, director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $270M from 30 investors (100% of the $50M target) as of the latest filing. Patrick is listed as executive officer on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $3.97M from 15 investors (100% of the $3.97M target) as of the latest filing. Patrick is listed as executive officer, director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $48M from 6 investors (100% of the $48M target) as of the latest filing. Patrick is listed as director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Jeffrey Aronin is on 8 issuers in total — a repeat sponsor. Their page lists every one.
ANTONIO GRACIAS is on 82 issuers in total — a repeat sponsor. Their page lists every one.
Darien Parhad is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Timothy Cunniff is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
JUAN SABATER is on 62 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
Listed on the same filings as Patrick J. Morris. Their page shows their other deals.
One team, 8 deal companies. Patrick J. Morris is listed on 8 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Patrick J. Morris.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); KY (Kentucky Secretary of State — Business Entity Search (sosbes.sos.ky.gov), searched by issuer name, data as of Oct 24, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).
None of the 11 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Patrick J. Morris by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 11 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Patrick J. Morris is listed on: none on file. No website or social profile named in Castle Creek Biosciences, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #77,125 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Exton, PA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Patrick J. Morris appears on a new Form D, or when a court case or SEC action is matched to them. See plans →